- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/46 - Reoviridae, e.g. rotavirus, bluetongue virus, Colorado tick fever virus
Patent holdings for IPC class C12N 15/46
Total number of patents in this class: 55
10-year publication summary
3
|
2
|
1
|
4
|
2
|
1
|
1
|
0
|
1
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Oncolytics Biotech Inc. | 48 |
5 |
Medicago Inc. | 138 |
4 |
Mitsubishi Tanabe Pharma Corporation | 584 |
4 |
London School of Hygiene & Tropical Medicine | 25 |
3 |
Universidade de Santiago de Compostela | 315 |
3 |
Entos Pharmaceuticals Inc. | 38 |
3 |
The Regents of the University of California | 19989 |
2 |
Duke University | 3072 |
2 |
Intervet Inc. | 910 |
2 |
Xiamen University | 534 |
2 |
Boehringer Ingelheim Animal Health USA Inc. | 426 |
2 |
The Trustees of Columbia University in the City of New York | 3578 |
1 |
bioMerieux | 922 |
1 |
Biomune Company | 44 |
1 |
Centre hospitalier Regional universitaire de Tours | 40 |
1 |
Chung-Ang University Industry-Academy Cooperation Foundation | 433 |
1 |
Fundação Oswaldo Cruz - FIOCRUZ | 22 |
1 |
The Governors of the University of Alberta | 870 |
1 |
Innovascreen Inc. | 4 |
1 |
Intervet International B.V. | 1299 |
1 |
Other owners | 14 |